Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for energy industry professionals · Monday, May 6, 2024 · 709,361,380 Articles · 3+ Million Readers

Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

VANCOUVER, BC--(Marketwired - August 23, 2017) - Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB), announces an extension to the term of 8,850,770 common share purchase warrants (the "Warrants") originally issued on March 6, 2014. The warrants were issued as part of a private placement. The expiry dates will be extended as follows:

   
March 6, 2014  
Number of Warrants: 8,850,770
Original Expiry Date of Warrants: March 6, 2017
New Expiry Date of Warrants: November 30, 2017
Exercise Price of Warrants: $0.25
   

All other terms of the Warrants will remain unchanged.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

/EINPresswire.com/ -- For more information regarding this press release, please contact:

Christopher Hopton
CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release